Evidence map›Paper›PMID 36187029›Full record

ArticleThe Pan African medical journal2022

COVID-19 vaccine hesitancy in six geopolitical zones in Nigeria: a cross-sectional survey.

Babatunde Oluwatosin Ogunbosi, Michael Abel Alao, Olayinka Rasheed Ibrahim, Adaeze Chikaodinaka Ayuk, Rasheedat Mobolaji Ibraheem, Chioma Laura Odimegwu, David Chibuike Ikwuka, Patricia Akintan, OreOluwa Morakinyo, Ayomide Toluwanimi Adeyemi and 11 more

Abstract read
In one paragraph

Article in The Pan African medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Babatunde Oluwatosin OgunbosiDepartment of Paediatrics, College of Medicine University of Ibadan and University College Hospital, Ibadan, Oyo State, Nigeria.
Michael Abel AlaoUniversity College Hospital, Ibadan, Oyo State, Nigeria.
Olayinka Rasheed IbrahimDepartment of Paediatrics, Federal Medical Centre, Kastina, Kastina State, Nigeria.
Adaeze Chikaodinaka AyukDepartment of Paediatrics, College of Medicine University of Nigeria Enugu Campus, Enugu State, Nigeria.
Rasheedat Mobolaji IbraheemDepartment of Paediatrics and Child Health, University of Ilorin and University of Ilori, Kwara State, Nigeria.
Chioma Laura OdimegwuDepartment of Paediatrics, College of Medicine University of Nigeria Enugu Campus, Enugu State, Nigeria.
David Chibuike IkwukaDepartment of Human Physiology, College of Health Sciences, Nnamdi Azikiwe University Nnewi Campus, Nnewi, Nigeria.
Patricia AkintanDepartment of Paediatric, College of Medicine, University of Lagos, Lagos State, Nigeria.
OreOluwa MorakinyoUniversity College Hospital, Ibadan, Oyo State, Nigeria.
Ayomide Toluwanimi AdeyemiUniversity College Hospital, Ibadan, Oyo State, Nigeria.
Ridwan Muhammad JegaDepartment of Paediatrics, Usmanu Danfodiyo University Teaching Hospitals Sokoto, Sokoto State, Nigeria.
Temitayo Folorunso OlowookereMedical Department (Vaccines), GlaxoSmithKline Pharmaceutical Nigeria Ltd, Lagos, Nigeria.
Olaseinde Emmanuel BelloUniversity of Medical Sciences Teaching Hospital, Akure, Ondo State, Nigeria.
Bilkis Iyabo OwolabiDepartment of Paediatrics, General Hospital, Ilorin, Kwara State, Nigeria.
Abejegah ChukwuyemInfection Control and Research Centre, Community Health Department, Federal Medical Centre, Owo, Ondo State, Nigeria.
Lawan Maryah BukarDepartment of Paediatrics, University of Maiduguri Teaching Hospital, Maiduguri, Bauchi State, Nigeria.
Aliu RasakiDepartment of Paediatrics, Gombe State University and Federal Teaching Hospital Gombe, Gombe State, Nigeria.
Amudalat IssaChildren Specialist Hospital Ilorin, Kwara State, Nigeria.
Atana Uket EwaDepartment of Paediatrics, University of Calabar Teaching Hospital, Calabar, Nigeria.
Regina OladokunDepartment of Paediatrics, College of Medicine University of Ibadan and University College Hospital, Ibadan, Oyo State, Nigeria.
Olusegun Olusina AkinyinkaDepartment of Paediatrics, College of Medicine University of Ibadan and University College Hospital, Ibadan, Oyo State, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: the high expectations that heralded the development of COVID-19 vaccines has been plagued with vaccine hesitancy (VH). The prevalence and associated factors of COVID-19 VH in the six geopolitical zones in Nigeria are explored. Methods: using a cross sectional survey, a pre-tested and validated questionnaire on a "Google form" was distributed via social media platforms and hard copies in the six geopolitical zones of Nigeria. Included, using a chain-reference sampling technique, were healthcare workers (HCW), university students and adults in the general population. Participants who expressed unwillingness to receive COVID-19 vaccine in the event of an available vaccine were considered to have vaccine hesitancy. Frequency and percentage were used to describe categorical variables. Multivariable logistic regression analysis was used to assess for factors associated with VH. Level of significance was set at 5% on two-sided tails test. Results: among 1615 respondents, mean (standard deviation) age was 36.7 (11.3) years, and 847 (52.4%) were males. More than half were healthcare workers (943; 58.4%), 97.4% had at least secondary level of education, and majority 60.5% belonged to the upper social class. The prevalence of VH was 68.5% (1107/1615), and 67.2% preferred foreign manufactured COVID-19 vaccines. On multivariable regression analysis, residence in Northeast (AOR 6.01, 95% CI 2.24, 16.10) and Northwest (AOR 3.33, 95% CI 1, 48, 7.48) geopolitical zones, the Igbo ethnic group (AOR 1.88, 95% 1.10, 3.22), Christians (AOR 1.86, 95% 1.10, 3.14), nurses (AOR 3.50, 95% CI 1.25, 9.80), pharmacist (AOR 5.82, 95% CI 2.12, 16.32) and participants without confidence in foreign vaccines (AOR 4.13, 95% CI 2.99, 5.72) were at higher likelihood of VH. Conclusion: vaccine hesitancy is high among adults in Nigeria, with higher likelihood among the Igbo ethnic group, Christian faith, residence in Northeast and Northwest geopolitical zones and those with an aversion to foreign-made vaccines. Targeted interventions are required for the desired COVID-19 vaccine uptake rate and herd immunity.

Indexed as

COVID-19COVID-19 VaccinesAdultCross-Sectional StudiesFemaleHumansMaleNigeriaVaccination HesitancyCOVID-19 VaccinesCOVID-19Nigeriavaccine hesitancy

Identifiers

PMID36187029
PMCPMC9482243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.